Goodpasture’s disease in a patient with advanced lung cancer treated with nivolumab: An autopsy case report
- 19 May 2018
- journal article
- research article
- Published by Elsevier BV in Lung Cancer
- Vol. 122, 22-24
- https://doi.org/10.1016/j.lungcan.2018.05.015
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitorsKidney International, 2016
- Beyond Melanoma: Inhibiting The PD-1/PD-L1 Pathway in Solid TumorsImmunotherapy, 2016
- Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysisBMC Medicine, 2015
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerThe New England Journal of Medicine, 2012
- Stimulation of the PD-1/PDL-1 T-cell co-inhibitory pathway is effective in treatment of experimental autoimmune glomerulonephritisNephrology Dialysis Transplantation, 2011
- Cutting Edge Issues in Goodpasture’s DiseaseClinical Reviews in Allergy & Immunology, 2011
- Anti-GBM disease following CTLA4 blockade in a patient with metastatic melanomaClinical Kidney Journal, 2009
- The HLA complex in Goodpasture's disease: A model for analyzing susceptibility to autoimmunityKidney International, 1999
- Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying ImmunoreceptorImmunity, 1999
- Idiopathic Goodpasture’s SyndromeNephron, 1986